Analyst Upgrades – NYSE:NVS – Novartis (NYSE:NVS) Stock Gets Upgraded By Credit Suisse Group from Underperform ➝ Neutral to

ME Staff
-
0

Analyst Ratings For NYSE:NVS – Novartis (NYSE:NVS)

Today, NYSE:NVS – Novartis (NYSE:NVS) stock received an upgrade by Credit Suisse Group from Underperform ➝ Neutral.

Some recent analyst ratings include

  • 5/25/2018-Credit Suisse Group Upgrade from a “Underperform ➝ Neutral” rating to a “” rating.
  • 5/17/2018-JPMorgan Chase & Co. Reiterated Rating of Neutral.
  • 4/20/2018-Deutsche Bank Reiterated Rating of Neutral.
  • 1/15/2018-UBS Reiterated Rating of Neutral.
  • 1/2/2018-Nord/LB Reiterated Rating of Neutral.
  • 12/6/2017-Bank of America was Downgraded by analysts at Bank of America from a “Neutral ➝ Underperform” rating to a “” rating.
  • 10/25/2017-Barclays was Downgraded by analysts at Barclays from a “Equal Weight ➝ Underweight” rating to a “” rating.

Dividend information for NYSE:NVS – Novartis (NYSE:NVS)

NYSE:NVS – Novartis (NYSE:NVS) pays an annual dividend of $1.91 with a yield of 2.49% and an average dividend growth of -0.50% based on a 3 Year Average..

Dividend History for NYSE:NVS – Novartis (NYSE:NVS)

  • On 1/27/2017 NYSE:NVS – Novartis announced a Annual dividend of $2.3270 with an ex dividend date of 3/1/2017 which will be payable on 3/3/2017.
  • On 2/1/2016 NYSE:NVS – Novartis announced a Annual dividend of $2.34 with an ex dividend date of 2/24/2016 which will be payable on 2/26/2016.
  • On 2/4/2014 NYSE:NVS – Novartis announced a annual dividend of $2.7186 3.48% with an ex dividend date of 2/27/2014 which will be payable on 3/11/2014.
  • On 2/11/2013 NYSE:NVS – Novartis announced a annual dividend of $2.53 3.71% with an ex dividend date of 2/26/2013 which will be payable on 4/5/2013.

Recent Insider Trading Activity For NYSE:NVS – Novartis (NYSE:NVS)
NYSE:NVS – Novartis (NYSE:NVS) has insider ownership of 0.01% and institutional ownership of 10.97%.

  • On 4/23/2018 Institutes For Biomed Novartis, Major Shareholder, bought 766,666 with an average share price of $15.00 per share and the total transaction amounting to $11,499,990.00.
  • On 7/5/2017 Bioventures Ltd Novartis, Major Shareholder, bought 266,667 with an average share price of $15.00 per share and the total transaction amounting to $4,000,005.00.
  • On 5/11/2016 Institutes For Biomed Novartis, Major Shareholder, bought 277,777 with an average share price of $18.00 per share and the total transaction amounting to $4,999,986.00.
  • On 2/17/2016 Bioventures Ltd Novartis, Major Shareholder, bought 375,000 with an average share price of $8.00 per share and the total transaction amounting to $3,000,000.00.
  • On 9/22/2014 Bioventures Ltd Novartis, Major Shareholder, bought 325,000 with an average share price of $15.00 per share and the total transaction amounting to $4,875,000.00.

Recent Trading Activity for NYSE:NVS – Novartis (NYSE:NVS)
Shares of NYSE:NVS – Novartis closed the previous trading session at 76.77 up +0.60 0.79% with 76.83000183105469 shares trading hands.